Axonics, Inc. Common Stock
AXNX
AXNX was delisted on the 14th of November, 2024.
236 hedge funds and large institutions have $2.83B invested in Axonics, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 107 increasing their positions, 67 reducing their positions, and 25 closing their positions.
60% more repeat investments, than reductions
Existing positions increased: 107 | Existing positions reduced: 67
12% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 25
0% more funds holding
Funds holding: 235 → 236 (+1)
9% less capital invested
Capital invested by funds: $3.12B → $2.83B (-$293M)
31% less call options, than puts
Call options by funds: $6.42M | Put options by funds: $9.34M
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$62.5M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$26.7M |
| 3 |
Renaissance Technologies
New York
|
+$22.1M |
| 4 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$18.7M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$18.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
-$44.4M |
| 2 |
Millennium Management
New York
|
-$22.3M |
| 3 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$20.9M |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$18M |
| 5 |
Man Group
London,
United Kingdom
|
-$15.4M |
AXNX Hedge Fund Activity: Q1 2023 in Review
236 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Axonics, Inc. Common Stock (AXNX) for Q1 2023, worth a combined $2.83B — down 9.4% from $3.12B a quarter earlier.
Buyers outnumbered sellers: 28 funds opened new AXNX positions and 25 closed out — a net gain of 3 holders — while 107 added to existing stakes and 67 trimmed.
The largest buyer was Point72 Asset Management, opening a new position worth an estimated $62.5M. The largest seller was Polar Capital Holdings, exiting entirely with an estimated $44.4M sold.
- 236 institutional investors held Axonics, Inc. Common Stock (AXNX) as of Q1 2023, up from 235 in Q4 2022.
- Funds reported $2.83B of Axonics, Inc. Common Stock stock for Q1 2023, down 9.4% quarter-over-quarter.
- 28 funds opened new Axonics, Inc. Common Stock positions in Q1 2023 and 25 closed out, a net change of +3 holders.
- The largest Axonics, Inc. Common Stock buyer in Q1 2023 was Point72 Asset Management, an estimated $62.5M added.
- The largest Axonics, Inc. Common Stock seller in Q1 2023 was Polar Capital Holdings, an estimated $44.4M sold.
Based on aggregated 13F filings for Q1 2023.